Skip to main content

What drugs are contained in Vyxeos?

Medically reviewed by Carmen Pope, BPharm. Last updated on March 22, 2024.

Official answer

by Drugs.com

Vyxeos contains a fixed-dose combination of daunorubicin and cytarabine, two chemotherapy (cancer) drugs, surrounded by a liposomal coating. This is a coating made of fat-like material which provides a way for daunorubicin and cytarabine to safely get to the bone marrow while limiting their effect on healthy tissue.

Vyxeos may be used to treat adults with acute myeloid leukemia (AML) caused by previous chemotherapy treatment or AML with myelodysplasia-related changes (AML-MRC). Vyxeos may also be used in children aged one year and older to treat newly-diagnosed therapy-related t-AML or AML with myelodysplasia-related changes (AML-MRC).

References
  • Vyxeos (daunorubicin and cytarabine) [Package Insert] Jazz Pharmaceuticals, Inc. https://www.drugs.com/pro/vyxeos.html
  • Daunorubicin and Cytarabine (Liposomal) Chemocare. https://chemocare.com/chemotherapy/drug-info/daunorubicin-and-cytarabine-liposomal.aspx
  • Jazz Pharmaceuticals Announces FDA Approval of Additional Indication for Vyxeos (daunorubicin and cytarabine) for the Treatment of Secondary Acute Myeloid Leukemia in Pediatric Patients https://www.drugs.com/newdrugs/jazz-pharmaceuticals-announces-fda-approval-additional-indication-vyxeos-daunorubicin-cytarabine-5476.html

Read next

Doxorubicin is considered one of the strongest chemotherapy drugs for breast cancer ever invented. It can kill cancer cells at every point in their life cycle, and it's used to treat a wide variety of cancers, not just breast cancer. Doxorubicin is also known as “The Red Devil” because it is a clear bright red color. It can cause your urine or other body fluids to turn a reddish color for 1 to 2 days after a dose is given, which is normal and temporary. Continue reading

Generally, small cell lung cancer (SCLC) is worse than non-small cell lung cancer (NSCLC). SCLC accounts for about 10-15% of people who have lung cancer and is the most aggressive form of lung cancer. SCLC usually starts in the breathing tubes (bronchi), and although the cells are small, they grow very quickly and create large tumors. Early on in the course of the disease, there are rarely any symptoms. If caught early (limited-stage disease) 20-25% of people can be potentially cured. Extensive SCLC is more difficult to treat. Continue reading

A hereditary family history of lung cancer is one of the many risk factors for developing non-small cell lung cancer. About 8% of lung cancers are thought to be inherited or linked to gene changes, but smoking and air pollution remain the primary causes of lung cancer. Continue reading

Related medical questions

Drug information

Related support groups

Medical Disclaimer